======= MTNR1B ======= == Gene Information == * **Official Symbol**: MTNR1B * **Official Name**: melatonin receptor 1B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4544|4544]] * **UniProt**: [[https://www.uniprot.org/uniprot/P49286|P49286]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MTNR1B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MTNR1B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600804|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes one of two high affinity forms of a receptor for melatonin, the primary hormone secreted by the pineal gland. This gene product is an integral membrane protein that is a G-protein coupled, 7-transmembrane receptor. It is found primarily in the retina and brain although this detection requires RT-PCR. It is thought to participate in light-dependent functions in the retina and may be involved in the neurobiological effects of melatonin. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: High affinity receptor for melatonin. Likely to mediate the reproductive and circadian actions of melatonin. The activity of this receptor is mediated by pertussis toxin sensitive G proteins that inhibit adenylate cyclase activity. |7TM GPCR Srx| |7TM GPCR Srsx| |7tm 1| |melatonin receptor activity| |positive regulation of circadian sleep/wake cycle, non-REM sleep| |regulation of neuronal action potential| |negative regulation of transmission of nerve impulse| |positive regulation of circadian sleep/wake cycle, sleep| |negative regulation of cGMP-mediated signaling| |positive regulation of transmission of nerve impulse| |regulation of circadian sleep/wake cycle, non-REM sleep| |negative regulation of delayed rectifier potassium channel activity| |negative regulation of cytosolic calcium ion concentration| |negative regulation of voltage-gated potassium channel activity| |regulation of cGMP-mediated signaling| |positive regulation of circadian rhythm| |regulation of circadian sleep/wake cycle, sleep| |regulation of transmission of nerve impulse| |regulation of delayed rectifier potassium channel activity| |negative regulation of potassium ion transmembrane transporter activity| |regulation of circadian sleep/wake cycle| |negative regulation of potassium ion transmembrane transport| |negative regulation of nervous system process| |positive regulation of behavior| |negative regulation of potassium ion transport| |negative regulation of insulin secretion| |negative regulation of cation channel activity| |negative regulation of peptide hormone secretion| |regulation of action potential| |regulation of potassium ion transmembrane transporter activity| |positive regulation of blood vessel diameter| |negative regulation of hormone secretion| |positive regulation of nervous system process| |negative regulation of ion transmembrane transporter activity| |regulation of behavior| |negative regulation of transporter activity| |regulation of potassium ion transmembrane transport| |negative regulation of cation transmembrane transport| |negative regulation of ion transmembrane transport| |regulation of potassium ion transport| |regulation of circadian rhythm| |negative regulation of transmembrane transport| |negative regulation of protein secretion| |regulation of nervous system process| |negative regulation of peptide secretion| |regulation of tube diameter| |regulation of blood vessel diameter| |regulation of tube size| |negative regulation of neuron apoptotic process| |negative regulation of ion transport| |vascular process in circulatory system| |regulation of cation channel activity| |regulation of insulin secretion| |negative regulation of protein transport| |glucose homeostasis| |negative regulation of establishment of protein localization| |carbohydrate homeostasis| |negative regulation of secretion by cell| |negative regulation of neuron death| |regulation of neuron apoptotic process| |regulation of peptide hormone secretion| |negative regulation of secretion| |G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger| |regulation of ion transmembrane transporter activity| |regulation of transmembrane transporter activity| |regulation of hormone secretion| |regulation of transporter activity| |regulation of neuron death| |camera-type eye development| |regulation of cytosolic calcium ion concentration| |regulation of cation transmembrane transport| |eye development| |visual system development| |sensory system development| |regulation of metal ion transport| |blood circulation| |circulatory system process| |chemical synaptic transmission| |anterograde trans-synaptic signaling| |regulation of membrane potential| |cellular calcium ion homeostasis| |trans-synaptic signaling| |calcium ion homeostasis| |synaptic signaling| |regulation of protein secretion| |cellular divalent inorganic cation homeostasis| |regulation of ion transmembrane transport| |negative regulation of transport| |divalent inorganic cation homeostasis| |regulation of peptide secretion| |negative regulation of intracellular signal transduction| |regulation of anatomical structure size| |regulation of hormone levels| |sensory organ development| |cellular metal ion homeostasis| |regulation of transmembrane transport| |regulation of system process| |metal ion homeostasis| |cellular cation homeostasis| |cellular ion homeostasis| |regulation of ion transport| |cation homeostasis| |regulation of protein transport| |inorganic ion homeostasis| |G protein-coupled receptor activity| |regulation of peptide transport| |cellular chemical homeostasis| |regulation of establishment of protein localization| |regulation of secretion by cell| |ion homeostasis| |regulation of secretion| |negative regulation of apoptotic process| |cellular homeostasis| |negative regulation of programmed cell death| |negative regulation of cell death| |regulation of protein localization| |chemical homeostasis| |cell-cell signaling| |negative regulation of molecular function| |negative regulation of multicellular organismal process| |negative regulation of signal transduction| |G protein-coupled receptor signaling pathway| |negative regulation of cell communication| |negative regulation of signaling| |integral component of plasma membrane| |regulation of apoptotic process| |regulation of programmed cell death| |negative regulation of response to stimulus| |homeostatic process| |regulation of cell death| |positive regulation of multicellular organismal process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of transport| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp512|Olaparib 4μM R08 exp512]]|-2.19| |[[:results:exp446|4-Nitroquinoline-1-oxide 0.5μM R08 exp446]]|-1.93| |[[:results:exp275|Citral 75μM R06 exp275]]|-1.85| |[[:results:exp536|Vitamin-D3 40μM R08 exp536]]|-1.81| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|-1.8| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-1.78| |[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|-1.77| |[[:results:exp358|FK-506 5μM R07 exp358]]|1.71| |[[:results:exp343|Centrinone 0.5μM R07 exp343]]|2.19| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.412| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6531 * **Expression level (log2 read counts)**: -5.6 {{:chemogenomics:nalm6 dist.png?nolink |}}